Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Bétrian

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Hematological Oncology|June 17, 2017
Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemiaSarah Bétrian, Sarah Guenounou, Isabelle Luquet, et al.
Pharmacogenomics|September 13, 2013
Irreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case reportAnne-Pascale Laurenty, Fabienne Thomas, Etienne Chatelut, et al.
BMC Cancer|July 23, 2022
Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancerAlejandra Martinez, Elodie Chantalat, Martina Aida Angeles, et al.
Journal of Gynecology Obstetrics and Human Reproduction|December 7, 2021
Basics of immunotherapy for epithelial ovarian cancerVirginie Bund, Henri Azaïs, Sabrina Bibi-Triki, et al.
Archives of Gynecology and Obstetrics|January 3, 2021
Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancerMartina Aida Angeles, Federico Migliorelli, Mathilde Del, et al.
Gynecologic Oncology|May 14, 2022
The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancerMartina Aida Angeles, Alicia Hernández, Asunción Pérez-Benavente, et al.
Clinical Sarcoma Research|May 12, 2017
Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's)Sarah Bétrian, Christophe Bergeron, Jean-Yves Blay, et al.
Journal of Gynecologic Oncology|August 25, 2021
Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancerMartina Aida Angeles, Bastien Cabarrou, Antonio Gil-Moreno, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2024
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapyVioleta Romero, Martina Aida Angeles, Elena Rodríguez González, et al.
Nature Communications|January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trialIsabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Hematological Oncology|June 17, 2017
Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemiaSarah Bétrian, Sarah Guenounou, Isabelle Luquet, et al.
Pharmacogenomics|September 13, 2013
Irreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case reportAnne-Pascale Laurenty, Fabienne Thomas, Etienne Chatelut, et al.
BMC Cancer|July 23, 2022
Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancerAlejandra Martinez, Elodie Chantalat, Martina Aida Angeles, et al.
Journal of Gynecology Obstetrics and Human Reproduction|December 7, 2021
Basics of immunotherapy for epithelial ovarian cancerVirginie Bund, Henri Azaïs, Sabrina Bibi-Triki, et al.
Archives of Gynecology and Obstetrics|January 3, 2021
Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancerMartina Aida Angeles, Federico Migliorelli, Mathilde Del, et al.
Gynecologic Oncology|May 14, 2022
The effect of major postoperative complications on recurrence and long-term survival after cytoreductive surgery for ovarian cancerMartina Aida Angeles, Alicia Hernández, Asunción Pérez-Benavente, et al.
Clinical Sarcoma Research|May 12, 2017
Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's)Sarah Bétrian, Christophe Bergeron, Jean-Yves Blay, et al.
Journal of Gynecologic Oncology|August 25, 2021
Effect of tumor burden and radical surgery on survival difference between upfront, early interval or delayed cytoreductive surgery in ovarian cancerMartina Aida Angeles, Bastien Cabarrou, Antonio Gil-Moreno, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2024
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapyVioleta Romero, Martina Aida Angeles, Elena Rodríguez González, et al.
Nature Communications|January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trialIsabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
Pageof 1